management of diabetes type i

Upload: natlene-christian

Post on 04-Apr-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/31/2019 Management of Diabetes Type i

    1/11

    MANAGEMENT OF DIABETES

    TYPE I:

  • 7/31/2019 Management of Diabetes Type i

    2/11

    Proper therapy involves integration of

    i.insulin therapy

    ii.dietary management

    iii physical exercise & fitness

    iv.emotional &social support in order toprevent the onset of acute & chroniccompications.

  • 7/31/2019 Management of Diabetes Type i

    3/11

    PRINCIPLES OF DIABETES MANAGEMENT:

    1.elimination of clinical features of uncontrolled

    diabetes.

    2. prevention of DKA.

    3. avoidance of hypoglycemia. 4. maintenance of normal growth & maturation.

    5. early detection of associated diseases.

    6. prevention of emotional disorders.

    7. prevetion of chronic vascular complications ofdiabetes.

  • 7/31/2019 Management of Diabetes Type i

    4/11

    Type of Insulin& Brand NamesOnset Peak

    Duration

    Role in BloodSugarManagement

    Rapid-ActingHumalog orlispro

    15-30min. 30-90 min

    3-5hours

    Rapid-acting insulin

    covers insulin needs

    for meals eaten at

    the same time as

    the injection. This

    type of insulin is

    used with longer-

    acting insulin.

    Novolog oraspart

    10-20min. 40-50 min.

    3-5hours

    Apidra orglulisine

    20-30min. 30-90 min.

    1-2hours

  • 7/31/2019 Management of Diabetes Type i

    5/11

    Short-Acting

    Regular (R)humulin or novolin

    30 min. -1hour 2-5 hours 5-8 hours

    Short-acting insulincovers insulinneeds for mealseaten within 30-60

    minutesVelosulin (for usein the insulinpump)

    30 min.-1hour 2-3 hours 2-3 hours

    Intermediate-Acting

    NPH (N) 1-2 hours 4-12 hours 18-24hours Intermediate-actinginsulin coversinsulin needs forabout half the dayor overnight. Thistype of insulin isoften combinedwith rapid- orshort-acting insulin.

    Lente (L) 1-2 hours 3-10 hours 18-24hours

  • 7/31/2019 Management of Diabetes Type i

    6/11

    Long-Acting

    Ultralente (U)30 min.-3 hours 10-20 hours

    20-36hours

    Long-acting insulin

    covers insulin

    needs for about

    one full day. This

    type of insulin isoften combined,

    when needed,

    with rapid- or

    short-acting

    insulin.

    Lantus 1-1hour

    No peak time;

    insulin isdelivered at asteady level 20-24hours

    Levemir ordetemir

    1-2hours 6-8 hours

    Up to24hours

  • 7/31/2019 Management of Diabetes Type i

    7/11

    Pre-Mixed*

    Humulin 70/30 30 min. 2-4 hours 14-24hours

    These products

    are generally

    taken twice a

    day before

    mealtime.

    Novolin 70/30 30 min. 2-12 hoursUp to24hours

    Novolog 70/30 10-20

    min.1-4 hours

    Up to24hours

    Humulin 50/50 30 min. 2-5 hours 18-24hours

    Humalog mix75/25 15 min. 30 min.-2 hours 16-20hours

    *Premixed insulins are a combination of specific proportions of

    intermediate-acting and short-acting insulin in one bottle or

    insulin pen (the numbers following the brand name indicate the

    percentage of each type of insulin).

  • 7/31/2019 Management of Diabetes Type i

    8/11

    DIABETICKETOACIDOSIS

    People with type 1 diabetes do not have enoughinsulin, a hormone the body uses to break downsugar (glucose) in the blood for energy. Whenglucose is not available, fat is broken down instead.

    As fats are broken down, acids called ketones buildup in the blood and urine. In high levels, ketonesare poisonous. This condition is known asketoacidosis.

    Blood glucose levels rise (usually higher than 300mg/dL) because the liver makes glucose to try tocombat the problem. However the cells cannot pullin that glucose without insulin

    http://www.ncbi.nlm.nih.gov/pubmedhealth/n/pmh_adam/A000305/http://www.ncbi.nlm.nih.gov/pubmedhealth/n/pmh_adam/A003482/http://www.ncbi.nlm.nih.gov/pubmedhealth/n/pmh_adam/A003482/http://www.ncbi.nlm.nih.gov/pubmedhealth/n/pmh_adam/A000305/
  • 7/31/2019 Management of Diabetes Type i

    9/11

    TREATMENT

    Insulin replacement

    Fluid and electrolyte replacement

    http://www.ncbi.nlm.nih.gov/pubmedhealth/n/pmh_adam/A002350/http://www.ncbi.nlm.nih.gov/pubmedhealth/n/pmh_adam/A002350/
  • 7/31/2019 Management of Diabetes Type i

    10/11

    Comparison of type 1 and 2 diabetes

    Feature Type 1 diabetes Type 2 diabetes

    Onset&diagnosis Sudden;peak age:11-12yrs;diagnosed before 20 yrsGradual;diagnosed after 40yrs

    Age at onsetMostly in Children (days orweeks);insulin levels low or

    nonexistent

    Mostly in adults.insulinlevels may be normal,mild

    elevated or depressed

    EtiologyCirculating islet cellantibodies presentunknown,butgenetic,viralor autoimmunefactors

    No Circulating islet cell

    antibodiesUnknown,but genetic &envt.factors areimportant.;riskfactos:obesity

  • 7/31/2019 Management of Diabetes Type i

    11/11

    Management

    Dependent on insulin toprevent ketoacidosis &sustain life

    Insulin,diet(mealplanning) &exercise

    Not Dependent on insulinto sustain life & notprone for ketoacidosis

    Insulin may requiredtemporarily for Periods ofstress like:

    surgery,trauma,orinfection

    diet(mealplanning)&exercise,occassionaly oralhypoglycemicagents&/insulin

    Body habitus Thin or normal Often obese

    Ketoacidosis Common Rare

    Autoantibodies Usually present Absent

    Endogenous insulin Low or absent Normal, decreasedor increased

    Concordancein identical twins 50% 90%

    Prevalence ~10-20% ~80-90%

    PreventionNone known,but futureresearch may clarifyetiology

    Even small weight lossesmay return plasmaglucoseto normal in many

    pts with this type

    http://en.wikipedia.org/wiki/Diabetic_ketoacidosishttp://en.wikipedia.org/wiki/Autoantibodieshttp://en.wikipedia.org/wiki/Autoantibodieshttp://en.wikipedia.org/wiki/Identical_twinhttp://en.wikipedia.org/wiki/Identical_twinhttp://en.wikipedia.org/wiki/Identical_twinhttp://en.wikipedia.org/wiki/Concordance_(genetics)http://en.wikipedia.org/wiki/Autoantibodieshttp://en.wikipedia.org/wiki/Diabetic_ketoacidosishttp://en.wikipedia.org/wiki/Obese